跳至主要内容
临床试验/NCT05312346
NCT05312346Unknown不适用

University Hospital

Sohag University1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2022年4月1日最近更新:
适应症

试验速览

阶段
不适用
入组人数
50
试验地点
1
主要终点
Serum creatinine

研究概览

简要总结

Anemia is common in patients on hemodialysis (HD) due to lack of erythropoietin (EPO) synthesis and iron deficiency is occurring in HD patients due to chronic blood loss through the dialysis circuit, repeated blood sampling, shortened red blood cell life span and lack of adherence to treatment .

Anemia is one of the most important complications that affects morbidity and mortality in chronic kidney disease (CKD) patients. It has significant impacts on those patients such as fatigue, weakness, shortness of breath, decreased quality of life, exercise capacity and physical activity, growth retardation and decreased cognitive functions, left ventricular hypertrophy, and congestive heart failure So, proper management of anemia is very important .

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
1 Year 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • (1) patients started dialysis in the age range of 1-18years. (2) Patient will be on regular hemodialysis.

排除标准

  • Children who have no other co existent hematological disorder .

结局指标

主要结局

Serum creatinine

时间窗: one year

serum creatinine

Iron profile

时间窗: one year

measure iron profile on blood

Hb g/dl

时间窗: one year

measure hemoglobin level

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Hanan Nagdy Fawzy

pediatric specialist

Sohag University

研究点 (1)

Loading locations...

相似试验